NZ706363A - Solid oral composition containing dyes for use in endoscopic diagnosis - Google Patents
Solid oral composition containing dyes for use in endoscopic diagnosisInfo
- Publication number
- NZ706363A NZ706363A NZ706363A NZ70636313A NZ706363A NZ 706363 A NZ706363 A NZ 706363A NZ 706363 A NZ706363 A NZ 706363A NZ 70636313 A NZ70636313 A NZ 70636313A NZ 706363 A NZ706363 A NZ 706363A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dye
- matrix
- optionally
- human
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/003—Thiazine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
- A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
- A61K49/0086—Polymersome, i.e. liposome with polymerisable or polymerized bilayered-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Optics & Photonics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261715981P | 2012-10-19 | 2012-10-19 | |
| EP12189206.1A EP2722058A1 (en) | 2012-10-19 | 2012-10-19 | Solid oral composition containing dyes for use in endoscopic diagnosis |
| PCT/EP2013/070060 WO2014060199A1 (en) | 2012-10-19 | 2013-09-26 | Solid oral composition containing dyes for use in endoscopic diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ706363A true NZ706363A (en) | 2019-03-29 |
Family
ID=47137560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ706363A NZ706363A (en) | 2012-10-19 | 2013-09-26 | Solid oral composition containing dyes for use in endoscopic diagnosis |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US20150283268A1 (enExample) |
| EP (3) | EP2722058A1 (enExample) |
| JP (1) | JP6267210B2 (enExample) |
| KR (1) | KR102207507B1 (enExample) |
| CN (3) | CN112891563A (enExample) |
| AR (1) | AR091984A1 (enExample) |
| AU (1) | AU2013331964B2 (enExample) |
| BR (1) | BR112015008772A2 (enExample) |
| CA (1) | CA2886201C (enExample) |
| DK (2) | DK2908866T3 (enExample) |
| ES (2) | ES2721916T3 (enExample) |
| FI (1) | FI3650048T3 (enExample) |
| HR (1) | HRP20190710T1 (enExample) |
| HU (1) | HUE043112T2 (enExample) |
| IL (1) | IL237907A (enExample) |
| IN (1) | IN2015DN02818A (enExample) |
| LT (1) | LT2908866T (enExample) |
| MX (1) | MX361737B (enExample) |
| NZ (1) | NZ706363A (enExample) |
| PL (1) | PL2908866T3 (enExample) |
| PT (1) | PT2908866T (enExample) |
| RS (1) | RS59152B1 (enExample) |
| RU (1) | RU2649783C2 (enExample) |
| TR (1) | TR201905800T4 (enExample) |
| TW (1) | TWI651102B (enExample) |
| WO (1) | WO2014060199A1 (enExample) |
| ZA (1) | ZA201502370B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019006216A (es) * | 2016-11-28 | 2019-08-22 | Cosmo Technologies Ltd | Composicion oral solida que contiene colorantes. |
| IT201900003113A1 (it) * | 2019-03-04 | 2020-09-04 | Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologna | Bevanda coadiuvante |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2129273C1 (ru) * | 1997-11-26 | 1999-04-20 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Способ эндоскопической флюоресцентной диагностики злокачественных опухолей полых органов |
| DE60005819T2 (de) | 1999-06-14 | 2004-05-06 | Cosmo S.P.A. | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe |
| ITMI991316A1 (it) | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
| US7230088B2 (en) * | 2001-07-03 | 2007-06-12 | Mallinckrodt, Inc. | Compounds for dual photodiagnosis and therapy |
| GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
| RU2253350C2 (ru) * | 2003-06-30 | 2005-06-10 | Государственное учреждение здравоохранения Иркутский Областной Диагностический Центр | Способ эндоскопического исследования желудка |
| US20050244368A1 (en) * | 2004-04-29 | 2005-11-03 | Pashankar Dinesh S | Pre-endoscopic use of polyethylene glycol compositions |
| FR2894253B1 (fr) * | 2005-12-06 | 2009-11-13 | Pentax Corp | Composition d'histocolorant pour endoscope |
| IT1398643B1 (it) | 2010-03-04 | 2013-03-08 | Cosmo Technologies Ltd | Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa |
-
2012
- 2012-10-19 EP EP12189206.1A patent/EP2722058A1/en not_active Withdrawn
-
2013
- 2013-09-26 DK DK13774382.9T patent/DK2908866T3/da active
- 2013-09-26 US US14/436,669 patent/US20150283268A1/en not_active Abandoned
- 2013-09-26 JP JP2015537181A patent/JP6267210B2/ja active Active
- 2013-09-26 CN CN202110120798.3A patent/CN112891563A/zh active Pending
- 2013-09-26 ES ES13774382T patent/ES2721916T3/es active Active
- 2013-09-26 HU HUE13774382A patent/HUE043112T2/hu unknown
- 2013-09-26 ES ES19159230T patent/ES3030697T3/es active Active
- 2013-09-26 CN CN202311335014.4A patent/CN117462704A/zh active Pending
- 2013-09-26 FI FIEP19159230.2T patent/FI3650048T3/fi active
- 2013-09-26 CA CA2886201A patent/CA2886201C/en active Active
- 2013-09-26 AU AU2013331964A patent/AU2013331964B2/en active Active
- 2013-09-26 MX MX2015004935A patent/MX361737B/es active IP Right Grant
- 2013-09-26 RU RU2015118584A patent/RU2649783C2/ru active
- 2013-09-26 EP EP13774382.9A patent/EP2908866B1/en active Active
- 2013-09-26 WO PCT/EP2013/070060 patent/WO2014060199A1/en not_active Ceased
- 2013-09-26 LT LTEP13774382.9T patent/LT2908866T/lt unknown
- 2013-09-26 TR TR2019/05800T patent/TR201905800T4/tr unknown
- 2013-09-26 BR BR112015008772A patent/BR112015008772A2/pt not_active Application Discontinuation
- 2013-09-26 IN IN2818DEN2015 patent/IN2015DN02818A/en unknown
- 2013-09-26 CN CN201380053741.XA patent/CN104755107A/zh active Pending
- 2013-09-26 PL PL13774382T patent/PL2908866T3/pl unknown
- 2013-09-26 RS RSP20190499 patent/RS59152B1/sr unknown
- 2013-09-26 DK DK19159230.2T patent/DK3650048T3/da active
- 2013-09-26 PT PT13774382T patent/PT2908866T/pt unknown
- 2013-09-26 NZ NZ706363A patent/NZ706363A/en unknown
- 2013-09-26 KR KR1020157010942A patent/KR102207507B1/ko active Active
- 2013-09-26 EP EP19159230.2A patent/EP3650048B1/en active Active
- 2013-09-26 HR HRP20190710TT patent/HRP20190710T1/hr unknown
- 2013-10-10 AR ARP130103688A patent/AR091984A1/es not_active Application Discontinuation
- 2013-10-15 TW TW102137094A patent/TWI651102B/zh active
-
2015
- 2015-03-23 IL IL237907A patent/IL237907A/en active IP Right Grant
- 2015-04-09 ZA ZA2015/02370A patent/ZA201502370B/en unknown
-
2019
- 2019-06-12 US US16/439,284 patent/US20200129643A1/en not_active Abandoned
-
2022
- 2022-12-20 US US18/085,372 patent/US20230130628A1/en not_active Abandoned
-
2025
- 2025-01-17 US US19/028,220 patent/US20250186626A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gupta et al. | Analysis of intestinal permeability in mice | |
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| EA026815B1 (ru) | Пероральная лекарственная форма, содержащая палоносетрон и нетупитант, капсульная лекарственная форма, способ лечения тошноты и рвоты | |
| JP2009102342A5 (enExample) | ||
| WO2011116139A3 (en) | Improved pharmaceutical compositions comprising cck- 8 and methods of delivery | |
| RU2008151950A (ru) | Фармацевтическая лекарственная форма пролонгированного высвобождения, содержащая фенилэфрин | |
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| IL278188B1 (en) | Sublingual formulation of riluzole | |
| KR20180025908A (ko) | 대장염의 치료 방법 | |
| JP2010538066A5 (enExample) | ||
| ES2773834T3 (es) | Métodos y composiciones para tratar la depresión usando ciclobenzaprina | |
| IL272834B2 (en) | Amantadine compositions, preparations thereof, and methods of use | |
| CN102218140B (zh) | 丹酚酸b和昔布类药物联合用药的抗肿瘤效果 | |
| CN110038002B (zh) | 丹酚酸a防治肌肉萎缩、肌病及肌肉骨骼并发症的用途 | |
| AR075866A1 (es) | Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica. | |
| ITMI20121317A1 (it) | Composizioni per il trattamento della fatica oncologica | |
| JP2021073275A (ja) | 甲状腺ホルモン又はそのアナログを提供する組成物及び方法 | |
| AR091984A1 (es) | Composicion oral solida que contiene colorantes para uso en diagnostico endoscopico | |
| BR112021001328A2 (pt) | composições de licopeno e métodos para proteger a pele contra a radiação ultravioleta | |
| KR20200066664A (ko) | 세균 감염증을 치료하는 방법 | |
| JP2013542262A5 (enExample) | ||
| ES2792850T3 (es) | Método para tratar la fibrosis pulmonar idiopática | |
| ES2922752T3 (es) | Composición combinada para prevenir o tratar el cáncer que comprende un derivado de benzofenona-tiazol como VDA y un inhibidor de topoisomerasa | |
| Dionisio et al. | Capsule endoscopy (CE) has a significantly higher diagnostic yield in patients with suspected and established non-stricturing Crohn disease (NSCD): a meta-analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2020 BY FRKELLY Effective date: 20190913 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2021 BY FRKELLY Effective date: 20200909 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2022 BY FRKELLY Effective date: 20210902 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2023 BY FRKELLY Effective date: 20220921 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2024 BY FRKELLY Effective date: 20230829 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2025 BY FRKELLY Effective date: 20240913 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2026 BY NINA RIBBENS Effective date: 20250912 |